Juan Carlos Turriate Gastulo

Array ( [id] => 813750 [patent_doc_number] => 07414023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Peptide ligands for prostate specific antigen' [patent_app_type] => utility [patent_app_number] => 10/363662 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 35 [patent_no_of_words] => 22443 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414023.pdf [firstpage_image] =>[orig_patent_app_number] => 10363662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754554 [patent_doc_number] => 07018981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Cyclic motilin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/362574 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23705 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/018/07018981.pdf [firstpage_image] =>[orig_patent_app_number] => 10362574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 934046 [patent_doc_number] => 06977241 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-20 [patent_title] => 'SH2 domain binding inhibitors' [patent_app_type] => utility [patent_app_number] => 10/362231 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 17798 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977241.pdf [firstpage_image] =>[orig_patent_app_number] => 10362231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440289 [patent_doc_number] => 20020128301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Non-nucleoside reverse transcriptase inhibitors' [patent_app_type] => new [patent_app_number] => 09/927254 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30901 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128301.pdf [firstpage_image] =>[orig_patent_app_number] => 09927254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951258 [patent_doc_number] => 20020006606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'MLK inhibitors for the treatment of neurological disorders' [patent_app_type] => new [patent_app_number] => 09/886964 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13036 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006606.pdf [firstpage_image] =>[orig_patent_app_number] => 09886964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367293 [patent_doc_number] => 20040092453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites' [patent_app_type] => new [patent_app_number] => 10/297620 [patent_app_country] => US [patent_app_date] => 2002-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2563 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092453.pdf [firstpage_image] =>[orig_patent_app_number] => 10297620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387748 [patent_doc_number] => 20040082759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Process for preparing distamycin derivatives' [patent_app_type] => new [patent_app_number] => 10/312261 [patent_app_country] => US [patent_app_date] => 2002-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4483 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082759.pdf [firstpage_image] =>[orig_patent_app_number] => 10312261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800397 [patent_doc_number] => 07425541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Enzyme-cleavable prodrug compounds' [patent_app_type] => utility [patent_app_number] => 09/879442 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29560 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425541.pdf [firstpage_image] =>[orig_patent_app_number] => 09879442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675308 [patent_doc_number] => 20040126810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors' [patent_app_type] => new [patent_app_number] => 10/296396 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3198 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126810.pdf [firstpage_image] =>[orig_patent_app_number] => 10296396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 948936 [patent_doc_number] => 06962972 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-08 [patent_title] => 'Derivatization of proteins' [patent_app_type] => utility [patent_app_number] => 10/276552 [patent_app_country] => US [patent_app_date] => 2001-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3888 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/962/06962972.pdf [firstpage_image] =>[orig_patent_app_number] => 10276552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544592 [patent_doc_number] => 07163921 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-16 [patent_title] => 'Peptide derivatives and medicinal compositions' [patent_app_type] => utility [patent_app_number] => 10/257238 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16712 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163921.pdf [firstpage_image] =>[orig_patent_app_number] => 10257238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 540762 [patent_doc_number] => 07169574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Fluorescence detection of proteases or peptidases' [patent_app_type] => utility [patent_app_number] => 10/240923 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5042 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169574.pdf [firstpage_image] =>[orig_patent_app_number] => 10240923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048625 [patent_doc_number] => 20020169132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Therapeutic anti-melanoma compounds' [patent_app_type] => new [patent_app_number] => 09/812238 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19088 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169132.pdf [firstpage_image] =>[orig_patent_app_number] => 09812238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721315 [patent_doc_number] => 20030055005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Gamma-secretase inhibitors' [patent_app_type] => new [patent_app_number] => 10/204962 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6264 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055005.pdf [firstpage_image] =>[orig_patent_app_number] => 10204962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361367 [patent_doc_number] => 20040014602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Novel echinocandin derivatives, preparation method and use thereof as fungicides' [patent_app_type] => new [patent_app_number] => 10/220829 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3678 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014602.pdf [firstpage_image] =>[orig_patent_app_number] => 10220829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839288 [patent_doc_number] => 20030036628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'p21 peptides' [patent_app_type] => new [patent_app_number] => 09/726470 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37568 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036628.pdf [firstpage_image] =>[orig_patent_app_number] => 09726470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732920 [patent_doc_number] => 07037896 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/111427 [patent_app_country] => US [patent_app_date] => 2000-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3520 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037896.pdf [firstpage_image] =>[orig_patent_app_number] => 10111427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634167 [patent_doc_number] => 07129224 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof' [patent_app_type] => utility [patent_app_number] => 10/333641 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7429 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129224.pdf [firstpage_image] =>[orig_patent_app_number] => 10333641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630432 [patent_doc_number] => 07132392 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-07 [patent_title] => 'Inhibition of cell motility and angiogenesis by inhibitors of Grb2-SH2-domain' [patent_app_type] => utility [patent_app_number] => 10/111192 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 11988 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132392.pdf [firstpage_image] =>[orig_patent_app_number] => 10111192 [rel_patent_id] =>[rel_patent_doc_number] =>)